Cargando…

MET expression during prostate cancer progression

Tyrosine-kinase inhibitors of the hepatocyte growth factor receptor MET are under investigation for the treatment of hormone-refractory prostate cancer (HRPC) metastasis. Analysis of MET protein expression and genetic alterations might contribute to therapeutic stratification of prostate cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verhoef, Esther I., Kolijn, Kimberley, De Herdt, Maria J., van der Steen, Berdine, Hoogland, A. Marije, Sleddens, Hein F.B.M., Looijenga, Leendert H.J., van Leenders, Geert J.L.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058736/ https://www.ncbi.nlm.nih.gov/pubmed/27105539 http://dx.doi.org/10.18632/oncotarget.8829

Ejemplares similares

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma
por: De Herdt, Maria J., et al.
Publicado: (2016)

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
por: Kolijn, Kimberley, et al.
Publicado: (2015)

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer
por: Hoogland, A. Marije, et al.
Publicado: (2016)

The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies
por: De Herdt, Maria J., et al.
Publicado: (2022)

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015)

Comparison of RNA extraction kits and histological stains for laser capture microdissected prostate tissue
por: Kolijn, Kimberley, et al.
Publicado: (2016)

The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
por: De Herdt, Maria J., et al.
Publicado: (2021)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
por: Rodríguez-Blanco, Giovanny, et al.
Publicado: (2018)

Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer
por: Duijvesz, Diederick, et al.
Publicado: (2019)

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases
por: Böttcher, René, et al.
Publicado: (2016)

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading
por: van Leenders, Geert J L H, et al.
Publicado: (2020)

Non-prostatic pathology on prostate needle-biopsy – colorectal carcinoid: a case report
por: van den Bergh, Roderick CN, et al.
Publicado: (2009)

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
por: van Agthoven, Ton, et al.
Publicado: (2016)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer
por: van Leenders, Geert J. L. H., et al.
Publicado: (2011)

PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays
por: de Jong, Joep J., et al.
Publicado: (2021)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens
por: Hollemans, Eva, et al.
Publicado: (2019)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma
por: Stelloo, Suzan, et al.
Publicado: (2016)

Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta‐analysis
por: Blok, Joost M., et al.
Publicado: (2020)

c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
por: Scheri, Katia Corano, et al.
Publicado: (2018)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
por: Scheri, Katia Corano, et al.
Publicado: (2018)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

Three‐dimensional architecture of common benign and precancerous prostate epithelial lesions
por: Verhoef, Esther I, et al.
Publicado: (2019)

Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns
por: Verhoef, Esther I., et al.
Publicado: (2019)

Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands
por: Deukeren, Désirée van, et al.
Publicado: (2022)

On cribriform prostate cancer
por: Kweldam, Charlotte F., et al.
Publicado: (2018)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
por: van Agthoven, Ton, et al.
Publicado: (2017)

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors
por: Looijenga, Leendert H.J., et al.
Publicado: (2020)

Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis
por: Elzinga-Tinke, Jenny E, et al.
Publicado: (2015)

DMRforPairs: identifying Differentially Methylated Regions between unique samples using array based methylation profiles
por: Rijlaarsdam, Martin A, et al.
Publicado: (2014)

Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
por: Hansum, Tim, et al.
Publicado: (2021)

VASA mRNA (DDX4) detection is more specific than immunohistochemistry using poly- or monoclonal antibodies for germ cells in the male urogenital tract
por: Boellaard, Willem P.A., et al.
Publicado: (2017)

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
por: Lobo, João, et al.
Publicado: (2020)

Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology
por: Looijenga, Leendert H. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ttp0c1l7nvvaflp9k6ua4jilfa